Focus: ReGenX Biosciences is a gene therapy and biologics-focused biotechnology company headquartered in Rockville, MD, operating in the specialized gene therapy segment.
Profile data last refreshed 3h ago · AI intelligence enriched 1mo ago
Growing — net +5 jobs in 30d
5 jobs added vs 0 removed. Steady team buildout.
ReGenX appears early-stage or inactive with limited public visibility; only pursue if you have direct network insight into their current strategy and funding status.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ReGenX Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ReGenX Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo